US · WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES · SMALL CAP
Fuse Medical, Inc. FZMD
12 fiscal years on record · USD · FY2022 reported
SEC FILINGS ONLY
Revenue · FY2022
$18.6M
▼ 8.7% vs FY2021
EPS · FY22
$0.04
Dividend / sh · FY22
—
Payout · FY22
—
ROE · FY22
—
Net margin · FY22
16.6%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 18.6M
Revenue, FY2022 · full 12-year series below
Revenue
Net income
17 cents of every revenue dollar became profit this year.
Per share
USD 0.04
Diluted EPS, FY2022
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2022
ROE
Operating margin-4.4%
Net margin16.6%
Return on assets16.3%
Returned to shareholders
—
returned in FY2022 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−6.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−6.6%
−6.7%
Net income
+34.7%
EPS, diluted
+0.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.07B
Shares outstanding, FY2022
Change, 5 years+12.1%
Change, 10 years—
The share count grew 12% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 19.8M
total assets, end of FY2022
Total assetsUSD 19.8M
EquityUSD -310,854.00
CashUSD 147,854.00
Current ratio1.11×
Equity funds -2% of total assets.
History
12 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
·
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
0.0
·
·
Income tax $B
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
·
·
·
·
Net income $B
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
EPS, diluted $
0.04
−0.02
−0.02
−0.05
0.05
0.04
0.33
−0.13
−0.37
0.15
−0.03
−0.03
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
·
·
·
−2712.3
·
53.5
32.4
−19.6
−598.9
296.1
−251.5
−213.0
Shares out B
0.07
0.07
0.07
0.07
0.07
0.07
0.02
0.01
0.01
0.01
0.00
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
44 of 44
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed